Stock Research for FMI

Featured Broker: Ally Invest

Get the due diligence for another stock.


FMI Stock Chart & Research Data

The FMI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FMI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


FMI Due diligence Resources & Stock Charts

The FMI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FMI Detailed Price Forecast - CNN Money CNN View FMI Detailed Summary - Google Finance
Yahoo View FMI Detailed Summary - Yahoo! Finance Zacks View FMI Stock Research & Analysis -

Stock Analysis

TradeIdeas View FMI Trends & Analysis - Trade-Ideas Barrons View FMI Major Holders - Barrons
NASDAQ View FMI Call Transcripts - NASDAQ Seeking View FMI Breaking News & Analysis - Seeking Alpha
Spotlight View FMI Annual Report - OTC Report View FMI OTC Short Report -
TradeKing View FMI Fundamentals - TradeKing Charts View FMI SEC Filings - Bar Chart
WSJ View Historical Prices for FMI - The WSJ Morningstar View Performance/Total Return for FMI - Morningstar
MarketWatch View the Analyst Estimates for FMI - MarketWatch CNBC View the Earnings History for FMI - CNBC
StockMarketWatch View the FMI Earnings - StockMarketWatch MacroAxis View FMI Buy or Sell Recommendations - MacroAxis
Bullish View the FMI Bullish Patterns - American Bulls Short Pains View FMI Short Pain Metrics -

Social Media Mentions

StockTwits View FMI Stock Mentions - StockTwits PennyStocks View FMI Stock Mentions - PennyStockTweets
Twitter View FMI Stock Mentions - Twitter Invest Hub View FMI Investment Forum News - Investor Hub
Yahoo View FMI Stock Mentions - Yahoo! Message Board Seeking Alpha View FMI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for FMI - Insider Cow View Insider Transactions for FMI - Insider Cow
CNBC View FMI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FMI - OTC Markets
Yahoo View Insider Transactions for FMI - Yahoo! Finance NASDAQ View Institutional Holdings for FMI - NASDAQ

Stock Charts

FinViz View FMI Stock Insight & Charts - StockCharts View FMI Investment Charts -
BarChart View FMI Stock Overview & Charts - BarChart Trading View View FMI User Generated Charts - Trading View

Latest Financial News for FMI

With new blood test, Roche dives deeper into personal cancer care
Posted on Monday September 24, 2018

Swiss drugmaker Roche upped its bet on personalised cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from solid tumours from a patient's blood. The blood test, called FoundationOne Liquid, is among initial products to emerge from Foundation Medicine after Roche spent $2.4 billion on the U.S.-based genetic profiling company this year on the conviction that future cancer treatment will be tailored to individual characteristics of a patient's tumour.

Incyte, Foundation Medicine Partner for Companion Diagnostics
Posted on Wednesday September 12, 2018

Incyte (INCY) inks an agreement with Foundation Medicine for the development of companion diagnostics (CDx) for Incy's selective FGFR Inhibitor, pemigatinib.

Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy
Posted on Monday August 06, 2018

Foundation Medicine, today announced the publication of the results of a large study demonstrating that its novel, investigational assay to measure blood tumor mutational burden (bTMB) can help predict response to the anti-PD-L1 immunotherapy, atezolizumab, (TECENTRIQ®) in patients with previously treated non-small cell lung cancer (NSCLC). The study, published in the journal Nature Medicine, was the result of a collaboration between Foundation Medicine and Genentech, a member of the Roche Group, and demonstrates the potential of bTMB to expand precision oncology approaches for patients with advanced cancers, including metastatic lung cancer. In addition, these results show that bTMB may be an independent predictor of clinical benefit, regardless of PD-L1 expression as assessed by immunohistochemistry.

Roche Purchases Shares in Tender Offer for FMI
Posted on Tuesday July 31, 2018

OTCQX: RHHBY) and Foundation Medicine, Inc. (FMI) today announced that Roche`s wholly owned subsidiary 062018 Merger Subsidiary, Inc. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of Foundation Medicine not already owned by Roche or its affiliates, at a price of $137.00 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 30 July 2018 and was not extended.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.